About Us

GSK Vaccines

Globally, We offer >40 vaccines for 22 disease.

Our Purpose

Is to improve the quality of life by enabling people to do more, feel better and live longer.

GlaxoSmithKline Pharmaceuticals Ltd. started in the year 1924 in India, is one of the most established pharmaceuticals company. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer.

GSK India product portfolio includes prescription medicines and vaccines (GSK Biologicals).
  • Prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases.
  • Vaccines portfolio includes vaccines against diseases like Pneumococcal disease, Measles, Mumps, Rubella & Chickenpox, Hepatitis A and B, Rotavirus & Cervical Cancer to name a few.

Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.

The vaccines in our portfolio have been helping to protect people from serious disease for well over 100 years, with our Marietta (US) site dedicated to smallpox vaccine production since 1882. Today, our vaccines continue to tackle some of the world’s most devastating diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza.

We have made commitments in four key areas, each of which relates to improving vaccination rates across the globe.

Access

Making our vaccines available to as many people who need them as possible; in one way or another, all of the Global Vaccine Action Plan (GVAP)’s imperatives relate to the issue of access.

Innovation

Innovating where it really counts, in line with imperatives, we invest in research and development to create new vaccines that meet real healthcare needs around the world.

Quality

Staking our reputation on the quality of our vaccines; we are committed to the highest standards of quality in everything we do; the GVAP is right to emphasize the importance of maintaining quality in its first imperative

Collaboration

Partnering widely with others to improve access, to innovate and to enhance the quality and efficacy of vaccines and vaccination, in line with imperatives.

Share On